Los puntos clave no están disponibles para este artículo en este momento.
By utilizing the strategies outlined above, it may be possible to exploit differences between tumor and somatic cell DRR pathways, specifically their DSB repair mechanisms, to improve the therapeutic ratio of IR.
Santivasi et al. (Fri,) studied this question.